Why the world seems to tip – the inner ear, the blood pressure, and the complete evidence-based approach to regaining your footing

The Symptom That Comes Without Warning

You stand up from your desk and the room briefly swims. You roll over in bed and the ceiling suddenly spins. You are walking normally and then, without provocation, you feel momentarily unsteady – as if the ground has shifted under you. Sometimes there is accompanying nausea, a brief flash of nausea, or a feeling of being disconnected from your surroundings. Sometimes it is a persistent, low-level unsteadiness that has replaced the confident, unconscious balance you used to take entirely for granted.

Dizziness and balance changes are among the most unexpected and most disorienting symptoms of the menopausal transition. Unlike hot flushes or sleep disruption, they are not widely discussed, not widely expected, and not widely attributed to hormonal change by the women who experience them or, frequently, by the clinicians they consult.

Yet the mechanistic and clinical evidence is clear. The onset of menopause, marked by hormonal fluctuations and a decline in estrogen levels, is suggested to be linked to increased susceptibility to vestibular disturbances. The vestibular system, crucial for balance and spatial orientation, is influenced by hormonal changes during menopause, potentially contributing to the emergence of vertigo symptoms. This interplay between hormones and the vestibular system is a burgeoning area of research with clinical implications, offering insights into novel diagnostic and therapeutic approaches for managing postmenopausal women with vestibular disorders.

This article explains the multiple mechanisms through which hormonal change disrupts balance, distinguishes between the clinical presentations (vertigo is not the same as dizziness is not the same as unsteadiness), identifies the warning signs that require urgent clinical assessment, and provides the complete evidence-based management approach.

Part 1: First, the Terminology – Dizziness, Vertigo, and Unsteadiness Are Not the Same

These three terms are frequently used interchangeably, but they describe different experiences with different clinical causes:

Dizziness (or lightheadedness) – a non-specific sensation of feeling faint, woozy, or as if you might lose consciousness. Typically experienced as a feeling inside the head rather than a sensation of environmental movement. Associated with drops in blood pressure, hypoglycemia, dehydration, and anemia.

Vertigo – a specific sensation of spinning or movement – either of yourself or of your surroundings – that is not actually occurring. Vertigo is not the same as dizziness. Vertigo involves a false sense of motion, while dizziness is characterized by feelings of lightheadedness or unsteadiness. Vertigo is caused by dysfunction of the vestibular system (inner ear or central vestibular pathways). It may be accompanied by nausea, nystagmus (involuntary eye movement), and vomiting.

Unsteadiness or imbalance – a persistent sense of being off-balance or of difficulty coordinating movement. Not a spinning sensation, not a feeling of fainting – more a general insecurity about movement, particularly on uneven surfaces, in low light, or when turning the head quickly.

During perimenopause and menopause, a woman may experience all three, sometimes simultaneously, sometimes sequentially. Understanding which type is dominant guides both the clinical assessment and the management approach.

Part 2: Four Distinct Mechanisms of Balance Disruption

Mechanism 1: Estrogen and the Inner Ear

The inner ear is the primary organ of balance in the human body. Its vestibular component – comprising the semicircular canals (which detect rotational movement) and the otolith organs (the utricle and saccule, which detect linear acceleration and head tilt) – provides the principal sensory input to the brain’s balance-processing centers.

Estrogen receptors are located in the inner ear, which helps the body maintain physical balance. Studies suggest that low estrogen levels may impact receptor function, potentially increasing the risk of vertigo.

The presence of estrogen receptors throughout the inner ear – in the vestibular hair cells, the endolymph-producing cells, and the vestibular ganglia – means that estrogen is not an incidental influence on balance but a direct regulator of inner ear function. When estrogen levels fall or fluctuate during perimenopause, multiple inner ear functions are simultaneously disrupted:

Endolymph production and composition – the endolymph, the fluid that fills the semicircular canals and otolith organs, is produced and regulated by estrogen-sensitive cells. Changes in endolymph volume and ionic composition directly affect the sensitivity and accuracy of vestibular hair cell signalling. This is the same mechanism through which Ménière’s disease produces its characteristic episodes of vertigo – endolymph dysregulation.

Otoconia stability – the otolith organs contain tiny calcium carbonate crystals called otoconia (or canaliths) that physically deflect with changes in head position and gravity, stimulating the hair cells that signal balance information to the brain. Estrogen plays a direct role in calcium metabolism throughout the body – including in the production, maintenance, and resorption of otoconia.

Estrogen helps maintain the stability of the crystals in your inner ear and changes in estrogen levels can affect the crystal stability and formation. This can cause a condition called benign paroxysmal positional vertigo (BPPV). BPPV happens when tiny calcium crystals in the inner ear get loose and disrupt the normal fluid movement in the ear canals, which help us maintain balance.

The evidence for this connection is clear. Two lines of evidence confirm the perimenopausal BPPV association: the existence of estrogen receptors in the inner ear, otoconial malformations in osteopenic/osteoporotic rats, changes in otoconin 90 (the principal protein component of otoconia) caused by hormone replacement therapy, impaired calcium absorption following estrogen deprivation corrected by estrogen replacement therapy, and epidemiological evidence showing higher BPPV rates in perimenopausal and postmenopausal women compared to age-matched premenopausal women.

Mechanism 2: Orthostatic Hypotension – The Blood Pressure Drop

Estrogen normally keeps blood vessels flexible and responsive. Without it, blood pressure can dip suddenly, especially when standing up quickly. That drop, called orthostatic hypotension, briefly cuts blood flow to the brain and brings on that woozy, off-balance feeling.

In the estrogen-replete state, blood vessel tone is actively maintained by estrogen’s direct effects on vascular smooth muscle and endothelial function – including its stimulation of nitric oxide production, which maintains vessel flexibility and appropriate vasodilation. When estrogen falls, this vascular regulatory function is impaired. The compensatory mechanisms that maintain blood pressure during the transition from lying or sitting to standing – vasoconstriction of the lower body vessels, increased heart rate, and peripheral resistance – become sluggish. Blood briefly pools in the lower extremities rather than being rapidly redistributed to the brain. The result is a transient cerebral hypoperfusion experienced as lightheadedness, visual greying, and unsteadiness.

This orthostatic hypotension is distinct from vertigo – it is characterized by positional triggering (standing up, particularly from a lying position), brief duration (seconds to a minute), and the characteristic lightheaded quality rather than a spinning sensation. Hot flushes worsen it acutely: the vasodilation that produces a hot flush further reduces peripheral vascular resistance, and the subsequent sweating produces dehydration that reduces circulating blood volume – both of which compound the blood pressure drop on standing.

Mechanism 3: Vestibular Migraine – The Most Under-Diagnosed Cause

Vestibular migraine is the most common cause of recurrent dizziness in women of perimenopausal age – and one of the most frequently missed diagnoses. Vestibular migraine may be an important cause of dizziness/vertigo in the perimenopausal period.

Vestibular migraine is a migraine variant in which the vestibular pathway – rather than or in addition to the pain pathway – is primarily affected. The hallmark is episodic vertigo or dizziness lasting minutes to hours, with or without accompanying headache, in a patient with a personal or family history of migraine. Many women with vestibular migraine do not experience significant head pain during episodes – which is why the migraine connection is not made, and why they are simply told they have vertigo.

The perimenopausal period dramatically increases vestibular migraine frequency and severity through the same estrogen-withdrawal mechanism that drives the increase in conventional migraine attacks at this stage. The trigeminovascular pain pathway – the neural route through which migraine is mediated – is directly regulated by estrogen. When estrogen fluctuates erratically, the sensitivity of the trigeminovascular system increases, and vestibular migraine episodes occur more frequently and with less provocation.

Migraines impact up to 29% of women during menopause and are another potential cause of dizziness. Treatment of vestibular migraine follows migraine-specific protocols – not vestibular rehabilitation – which is why correct identification of the etiology is clinically critical.

Mechanism 4: Sleep Deprivation, Anxiety, and Neurological Dysregulation

The balance-regulating brain centers – the cerebellum, the brainstem, and the vestibulo-cerebellar tracts – require adequate sleep and neurochemical stability to integrate the sensory inputs that produce accurate balance. When you are deprived of adequate sleep, your brain and nervous system are less efficient at processing information and maintaining balance, making you more likely to feel lightheaded or unsteady.

The perimenopausal period impairs this neurological foundation through multiple pathways: sleep deprivation from night sweats and insomnia reduces cerebellar accuracy in balance integration; the elevated cortisol of HPA axis hyperreactivity amplifies the perceived severity of vestibular symptoms; and anxiety – significantly elevated during this transition – produces the characteristic non-rotatory dizziness and unsteadiness of the anxious nervous system. Anxiety can cause dizziness as well, making it important to take necessary steps to manage stress.

Additionally, blood sugar instability – driven by the increased insulin resistance of perimenopause – can produce episodes of hypoglycemia that manifest as dizziness, particularly before meals or after high-carbohydrate intake followed by an insulin spike.

Part 3: The Clinical Presentations – Identifying the Type You Are Experiencing

Benign Paroxysmal Positional Vertigo (BPPV)

BPPV is the most common vestibular disorder affecting perimenopausal women. Its clinical signature is unmistakable once recognized: brief (typically 10–60 seconds), intense spinning vertigo that is triggered by specific changes in head position – rolling over in bed, looking up, looking down, bending forward. Between episodes, the person feels completely normal.

BPPV results from otoconia that have become dislodged from the utricle and have migrated into the semicircular canals, where they interfere with the normal detection of head rotation by the vestibular hair cells. The posterior semicircular canal is involved in 60–90% of cases.

BPPV is diagnosed by the Dix-Hallpike maneuver (a clinical procedure in which the clinician moves the patient’s head to provoke the characteristic nystagmus) and is treated by canalith repositioning maneuvers – most notably the Epley maneuver – which physically guide the displaced otoconia back into the utricle through a series of precise head movements.

Ménière’s Disease

Ménière’s disease is a more complex and less common vestibular condition produced by endolymph excess in the inner ear (endolymphatic hydrops). Its clinical syndrome consists of four features: episodic vertigo lasting 20 minutes to several hours; fluctuating hearing loss; tinnitus (ringing or buzzing in the affected ear); and ear fullness. The hearing and tinnitus components distinguish Ménière’s from BPPV and vestibular migraine. The increased prevalence of Ménière’s disease in the perimenopausal period reflects the same endolymph-regulatory role of estrogen that drives its general vestibular vulnerability.

Orthostatic Hypotension Episodes

Characterized by: brief lightheadedness (not spinning) on standing; typical duration of seconds; often accompanied by visual darkening or greying at the edges; relieved by sitting or lying down; worse on hot days, after a hot shower, or following hot flushes; associated with dehydration and inadequate salt intake.

Vestibular Migraine

Characterized by: episodic dizziness or vertigo lasting minutes to hours; may or may not be accompanied by headache; often associated with nausea and light/sound sensitivity; triggered by migraine triggers (sleep deprivation, stress, hormonal fluctuations, caffeine, red wine); personal or family history of migraine; may alternate with conventional headache episodes.

Anxiety-Related Dizziness

Characterized by: chronic, persistent low-level unsteadiness or dizziness (rather than discrete episodes); not triggered by head movement; associated with feeling of unreality or depersonalization; often worse in open spaces or crowded environments; accompanied by other anxiety symptoms (palpitations, tension, hyperventilation); not position-dependent.

Part 4: When Dizziness Requires Urgent Clinical Assessment

The vast majority of dizziness during perimenopause has a hormonal or benign vestibular explanation. However, certain features require urgent clinical assessment to exclude serious secondary causes:

Seek urgent medical attention for:

• Sudden, severe, “thunderclap” onset of the worst dizziness of your life – may indicate a posterior fossa cerebrovascular event (cerebellar stroke or hemorrhage), which is a medical emergency
• Dizziness accompanied by sudden severe headache, double vision, slurred speech, facial numbness, or unilateral limb weakness – neurological emergency requiring immediate assessment
• Dizziness with sudden loss of hearing in one ear – may indicate cochlear hydrops, vascular event, or acoustic neuroma
• Dizziness after a fall or head trauma – may indicate traumatic inner ear injury or intracranial injury
• Progressive, worsening unsteadiness without discrete episodes – rather than episodic vertigo, a continuous progressive deterioration of balance warrants neurological assessment for cerebellar pathology
• Dizziness in a new onset diabetic or uncontrolled hypertensive patient – vascular and metabolic causes require specific management

Clinical investigations to request when dizziness is persistent and unexplained: thyroid function (TSH – both hypothyroidism and hyperthyroidism produce balance disturbances); full blood count (anemia); blood glucose; blood pressure measurement including lying and standing (orthostatic hypotension); B12 and folate; ECG (cardiac arrhythmia can cause dizziness); Holter monitoring if cardiac cause is suspected.

Part 5: The Evidence-Based Treatment Approach

1. The Epley Maneuver for BPPV: The Gold-Standard First-Line Treatment

For women whose dizziness is identified as BPPV, the Epley maneuver is the most effective and most directly curative treatment available. The Epley maneuver works by helping to reposition tiny crystals in the inner ear (canaliths) that cause the characteristic positional vertigo. Success rates are high: a single correctly performed Epley maneuver resolves BPPV in approximately 70–80% of cases at the first treatment, with repeat applications achieving resolution in 90%+ of cases.

The Epley maneuver can be learned from a healthcare professional – a neurologist, ENT specialist, vestibular physiotherapist, or trained GP – and then self-administered at home for subsequent episodes. Given that BPPV recurrence is common in perimenopausal women (due to the ongoing hormonal influence on otoconia stability), having this skill provides effective self-management.

The Semont-Liberatory maneuver and the Barbecue Roll maneuver are alternatives for atypical BPPV presentations or when the Epley maneuver cannot be performed. A vestibular physiotherapist can determine which maneuver is most appropriate based on which semicircular canal is affected.

2. Vestibular Rehabilitation Therapy (VRT)

For women with persistent balance difficulties, general vestibular hypofunction, or incomplete resolution after BPPV maneuvers, Vestibular Rehabilitation Therapy is the evidence-based physiotherapeutic intervention. Vestibular rehabilitation therapy describes different exercises and maneuvers that help with certain types of vertigo. These exercises retrain the brain to use other senses (like vision or touch). They can improve balance and help with feeling less unstable and dizzy.

VRT is delivered by a vestibular physiotherapist and includes: gaze stabilization exercises (training the visual system to compensate for vestibular deficits); balance training on increasingly unstable surfaces; habituation exercises (graduated exposure to provocative head movements that reduce the symptomatic response over time); and walking and functional balance training.

The evidence for VRT in postmenopausal vestibular dysfunction is strong: systematic reviews consistently demonstrate significant improvement in dizziness, fall risk, balance confidence, and quality of life in this population.

3. Managing Orthostatic Hypotension

For the blood-pressure-related dizziness of menopausal orthostatic hypotension, several practical strategies have strong evidence:

Rise slowly – when moving from lying to sitting to standing, allow 30–60 seconds at each transition before standing fully. This gives the baroreceptors time to compensate and prevents the sudden cerebral hypoperfusion that produces lightheadedness.

Hydration – maintaining adequate blood volume reduces the severity of orthostatic hypotension significantly. Staying well-hydrated maintains blood volume and reduces lightheaded spells. A minimum of 2 liters of water daily; more in hot weather or following night sweats.

Compression hosiery – graduated compression stockings reduce venous pooling in the lower extremities and significantly reduce the blood volume shift responsible for orthostatic hypotension on standing. Evidence-supported; inexpensive; available without prescription.

Sodium (salt) intake moderation – adequate dietary sodium maintains blood volume. Women with symptomatic orthostatic hypotension who are also following a very low sodium diet may benefit from moderate salt increase (in the absence of hypertension) – ideally discussed with a clinician.

Small, frequent meals – large meals divert blood flow to the digestive system, temporarily reducing cerebral perfusion. Eating regular, balanced meals and snacks helps smooth out blood sugar swings and keeps dizziness at bay.

Avoid trigger situations – prolonged standing, hot environments, hot showers, alcohol, and heavy meals are all triggers for orthostatic hypotension in susceptible women. Avoiding or modifying these situations reduces episode frequency.

4. Managing Vestibular Migraine

Vestibular migraine management follows the principles of conventional migraine management:

Lifestyle regulation – consistent sleep and wake times, regular meals, adequate hydration, caffeine management, and avoidance of identified triggers are the foundation. Treatment focuses on reducing the brain’s sensitivity to motion and sensory input through healthy lifestyle practices (consistent sleep, hydration, stress reduction), vestibular rehabilitation exercises, and in some cases, migraine-specific medications.

Preventive medications – for women with frequent vestibular migraine episodes (more than 3–4 per month), preventive treatment follows conventional migraine prophylaxis: beta-blockers (propranolol), amitriptyline, topiramate, or the newer CGRP antagonists (erenumab, fremanezumab). Common preventives include magnesium, riboflavin, CGRP inhibitors, tricyclic antidepressants.

Acute treatment – triptans can abort vestibular migraine episodes if taken at onset, though they are less reliably effective for the vestibular component than for pain. Antiemetics (prochlorperazine, ondansetron) are valuable for the nausea component and also have mild vestibulodepressant properties.

5. Nutritional and Supplemental Support

Magnesium glycinate (400–600 mg daily) – evidence-supported for both migraine prevention (directly relevant to vestibular migraine) and for the improvement of inner ear function through its role in calcium metabolism. Magnesium is a co-factor in the production and maintenance of otoconia – addressing the same biochemical system through which estrogen deficiency promotes BPPV. Multiple international headache societies recommend magnesium as a safe first-line preventive supplement.

Vitamin D – directly relevant to both BPPV (through its role in calcium metabolism and otoconia stability) and balance more broadly (through its role in muscle function and proprioception). Correcting vitamin D deficiency may improve calcium metabolism in the inner ear, potentially reducing the risk or severity of conditions like BPPV. Test and correct to above 50 nmol/L. Several studies show that vitamin D deficiency is significantly more common in women with recurrent BPPV, and that correction reduces recurrence rates.

Vitamin B12 – B12 deficiency (common in midlife women) produces vestibular and proprioceptive disturbances through its effects on peripheral nerve function. Testing and correcting B12 deficiency addresses a potentially reversible cause of balance disturbance.

Omega-3 fatty acids – anti-inflammatory; relevant to the inflammatory component of vestibular disorders and supportive of cochlear blood flow. 2–3g EPA+DHA daily.

Ginger – evidence-supported for nausea and motion sickness through its effects on 5-HT3 receptors in the gut-brain axis. Relevant as an adjunct for the nausea accompanying acute vestibular episodes. 250 mg ginger extract four times daily is the dose used in clinical trials.

Hydration – inadequate water intake is a documented risk factor for vestibular disorders. Maintaining minimum 2 liters daily is the baseline; more when additional fluid losses occur through hot flushes and night sweats.

6. Balance Training and Fall Prevention

For perimenopausal and postmenopausal women with persistent balance changes, structured balance training directly reduces fall risk – one of the most significant clinical consequences of menopausal balance deterioration. Falls and their consequences, including fractures, are a leading cause of morbidity and mortality in older women; proactive balance training during the menopausal transition is a genuinely preventive intervention.

Evidence-based balance interventions:

• Tai chi – the most extensively evidenced single exercise modality for fall prevention and balance improvement in midlife and older women. Improves proprioception, coordination, and balance confidence through its emphasis on weight shifting, slow controlled movement, and multidirectional challenges
• Yoga – particularly standing balance poses (Warrior sequences, Tree pose, Eagle pose) that challenge single-leg stability and proprioception
• Resistance training – builds the lower limb strength that provides the muscular basis for balance recovery; gluteal and quadriceps strength are the most critical determinants of the ability to catch a stumble
• Tandem walking, single-leg standing, and perturbation training – can be self-practiced or supervised, progressively increasing the challenge to the balance system

7. Managing Anxiety-Related Dizziness

For women whose dizziness has a significant anxiety component (persistent, non-positional, associated with other anxiety symptoms), addressing the anxiety directly is more effective than vestibular-specific treatment:

CBT has demonstrated specific benefit for persistent dizziness with an anxiety component, particularly the specific CBT protocol for Persistent Postural-Perceptual Dizziness (PPPD – a chronic form of anxiety-driven vestibular dysfunction in which the nervous system maintains a state of heightened vestibular vigilance long after the initial vestibular insult).

Mindfulness and breathing regulation – slow, diaphragmatic breathing directly reduces sympathetic nervous system tone, which amplifies the vestibular symptoms of anxiety-related dizziness. Five minutes of extended exhale breathing (inhale 4 counts, exhale 6–8 counts) reduces dizziness within a single session in anxious patients.

8. Hormone Therapy – The Direct Hormonal Approach

By replenishing estrogen, HRT can help rebalance the systems affected by hormonal decline, including those involved in balance and spatial orientation. The 2024 Cureus study points to a potential therapeutic role for HRT in reducing the frequency and severity of dizziness and vertigo in menopausal women.

The evidence for MHT specifically reducing vestibular symptoms is growing but not yet definitive – it is based primarily on the biological logic of restoring estrogen’s direct regulatory role in the inner ear, and on case series and observational data showing improvement in vestibular symptoms with hormonal therapy.

For women who are managing BPPV recurrence, Ménière’s disease, or general vestibular dysfunction in the context of other menopausal symptoms, discussing MHT with a menopause specialist is clinically appropriate – both to address the hormonal primary cause and to assess the vestibular benefit alongside the broader symptom profile.

Part 6: The Practical Daily Framework

For BPPV: Learn the Epley maneuver from a vestibular physiotherapist or ENT. Perform it at the first sign of positional vertigo. Avoid the provoking head position (whichever head turn triggers the episode) temporarily until resolution. Supplement vitamin D and magnesium (both support otoconia stability and calcium metabolism).

For orthostatic hypotension: Rise in stages. Drink 2+ liters of water daily. Compression stockings for significant symptoms. Eat regular small meals. Identify and avoid triggers (hot showers, alcohol, large meals before rising).

For vestibular migraine: Track episodes in a diary to identify pattern and triggers. Start magnesium (400 mg daily) and riboflavin (400 mg daily) as first-line preventive supplements. Maintain consistent sleep-wake times. Discuss migraine-specific prevention with a clinician if episodes are frequent.

For general balance deterioration: Incorporate balance-specific exercise (tai chi, yoga balance poses, single-leg standing practice) into weekly routine. Maintain adequate protein and vitamin D for muscle and nerve function. Request vestibular physiotherapy referral if balance insecurity is affecting confidence or activities.

For persistent unexplained dizziness: Request thyroid function, full blood count, B12, vitamin D, glucose, and lying/standing blood pressure from your GP. Discuss the symptom explicitly in the context of perimenopause – many clinicians do not volunteer the hormonal connection. Discuss MHT if other menopausal symptoms are also present.

The Conclusion

Dizziness and balance changes during perimenopause and menopause are hormonally coherent, mechanistically well-understood, and significantly under-recognized as menopause symptoms in both clinical and public discourse. They arise through four distinct but often simultaneous mechanisms – inner ear estrogen-receptor disruption, orthostatic hypotension, vestibular migraine amplification, and neurological dysregulation from sleep deprivation and anxiety – and each mechanism has specific, evidence-based management options.

The vestibular system, crucial for balance and spatial orientation, is influenced by hormonal changes during menopause, potentially contributing to the emergence of vertigo symptoms.

You do not have to accept a life of reaching for walls when you stand up, avoiding situations where unsteadiness would be embarrassing, or living in anxiety about the next spinning episode. The Epley maneuver resolves BPPV rapidly and reliably. Vestibular rehabilitation retrains the brain. Orthostatic hypotension responds to simple, immediate lifestyle modifications. Vestibular migraine has specific and effective prevention. And hormone therapy, for women for whom it is appropriate, directly addresses the hormonal origin of vestibular disruption.

Your footing can be recovered. With the right diagnosis and the right approach, it usually can.

For more useful articles and expert guidance, explore the Womeno app – your personal digital companion through the hormonal transition. Download the app HERE

Sources

1. Castillo-Bustamante M et al. Balance in Transition: Unraveling the Link Between Menopause and Vertigo. Cureus. 2024;16(4):e59277. PMC11135238. doi:10.7759/cureus.59277
2. Jeong S. Benign Paroxysmal Positional Vertigo Risk Factors Unique to Perimenopausal Women. PMC7596253. 2020. doi:10.3389/fneur.2020.00842
3. Winona Medical. Menopause & Vertigo: Causes & How to Manage It. bywinona.com. Updated March 2026. (Citing: Castillo-Bustamante et al. 2024; Bhatt DL et al. vasomotor and blood pressure research)
4. Versalie. Menopause Dizziness and Vertigo. versalie.com. March 2025.
5. Elektra Health. Everything You Need To Know: Dizziness In Menopause. elektrahealth.com. August 2025. (Citing: Park JH, Viirre E 2010 Vestibular migraine in perimenopause; Pagnini P et al. 2014)
6. HotPause Health. Vertigo in Menopause: Causes, Balance Issues & Treatment. hotpausehealth.com. May 2025. (Citing: Castillo-Bustamante et al. 2024; Vitamin D and BPPV research)
7. The HRT Club / Castillo-Bustamante M. Feeling Off Balance? Dizziness and Vertigo Might Be Menopause-Related.thehrtclub.com. June 2025. (Citing: Castillo-Bustamante et al. 2024 Cureus)
8. GoodRx / Caplan C MD (Medical Review). 5 Natural Remedies for Dizziness During Menopause. goodrx.com. August 2025. (Citing: Jeong S 2020; Castillo-Bustamante et al. 2024; Journal of International Advanced Otology hydration and vestibular disorders)
9. Sleep.me. Why Menopause Causes Dizziness and How to Treat It. sleep.me. June 2025.
10. Stanford ENT / Ohio Hearing Institute. Vestibular Migraine Overlaps with other Vestibular Disorders.med.stanford.edu. September 2025.
11. MedRxiv / Foundation University Islamabad. A Meta-Analysis of the Epley Maneuver’s Effect on Dizziness Handicap Index (DHI) Scores in Patients with Posterior Canal BPPV. medrxiv.org. 2025.
12. ClinicalTrials.gov NCT06625281. Effects of Epley’s Maneuver Versus Semont-Plus Maneuver Combined with Brandt-Daroff Exercises on Dizziness and Quality of Life in BPPV. 2024.
13. Park JH, Viirre E. Vestibular migraine may be an important cause of dizziness/vertigo in the perimenopausal period. Medical Hypotheses. 2010;75(5):409–414. doi:10.1016/j.mehy.2009.04.054
14. Teggi R et al. Inner ear, estrogens and the vestibular system. ACTA Otorhinolaryngologica Italica. 2008;28(2):49–56. PMC2790407.
15. Smith PF. Estrogen and the aging brain: Estrogen’s role in neuroprotection. Journal of Clinical Endocrinology & Metabolism. 2024. (Citing: 2023 review on estrogen and brain chemistry, nerve health)
16. Casani AP et al. Vitamin D and Repositioning Manoeuvres Efficacy in Treatment of BPPV: A Prospective Randomized Controlled Trial. Audiology and Neurotology. 2020.
17. Bhattacharyya N et al. Clinical Practice Guideline: Benign Paroxysmal Positional Vertigo (Update).Otolaryngology–Head and Neck Surgery. 2017;156(3_suppl):S1–S47.
18. McDonnell MN, Hillier SL. Vestibular rehabilitation for unilateral peripheral vestibular dysfunction. Cochrane Database of Systematic Reviews. 2015. doi:10.1002/14651858.CD005397.pub4
19. Huang S et al. Anxiety disorder in menopausal women and the intervention efficacy of mindfulness-based stress reduction. American Journal of Translational Research. 2023. (Referenced in GoodRx 2025)
20. PMC12565178. Reconsidering Hormone Replacement Therapy: Current Insights on Utilisation in Premenopausal and Menopausal Women: An Overview. 2025. (HRT mechanism and vestibular benefit context)